Latest filing: Wanbury Ltd - 524212 - Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company''s Facility At Tanuku, West Godavari District, Andhra Pradesh
ObservedCompany dossier
Wanbury
NSE:WANBURY · ISIN INE107F01022
- Close
- ₹305.9 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Wanbury
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹133.5 Cr · PAT ₹1.2 Cr.
Exchange XBRLLatest ownership: promoter group 43.02% and public 56.98% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Wanbury Ltd - 524212 - Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company''s Facility At Tanuku, West Godavari District, Andhra Pradesh
BSE · exchange filing
Observed
Source filing General Updates - Wanbury Limited
NSE · exchange filing
Observed
Source filing Wanbury Ltd - 524212 - Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company''s Facility At Tanuku, West Godavari District, Andhra Pradesh
BSE · exchange filing
Observed
Source filing General Updates - Wanbury Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹133.5 Cr
- Profit after tax
- ₹1.2 Cr
- EPS
- ₹0.38
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 43.02%
- Public
- 56.98%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL